EPM2A anticorps (AA 1-331)

N° du produit ABIN2261150

Détail du produit anti-EPM2A anticorps

Antigène: EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))

Épitope: AA 1-331

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp EPM2A est non-conjugé

Application: Western Blotting (WB)

Réactivité croisée: Humain

Réactivité croisée (Details): Calculated cross reactivity: Hu

Attributs du produit: Epilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)

Purification: Purified by Protein G immunoaffinity chromatography.

Immunogène: Purified, E. coli-derived full length recombinant human Laforin (rhLaforin, aa 1-331, UniProt # O95278).

Clone: 9H116

Isotype: IgG2b

Information d'application

Indications d'application: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Reconstitution: Reconstitute in PBS containing 0.02 % sodium azide.

Buffer: Supplied as lyophilized from a 0.2um sterile-filtered solution in PBS with 5 % trehalose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C

Détails sur EPM2A

Antigène: EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))

Autre désignation: Epilepsy, Progressive Myoclonus Type 2A (EPM2A Produits)

Synonymes: anticorps TG-B, anticorps Tg(TcraK,TcrbK)TG-BFlv, anticorps EPM2, anticorps MELF, anticorps laforin, anticorps EPM2A, laforin glucan phosphatase, anticorps epilepsy, progressive myoclonic epilepsy, type 2 gene alpha, anticorps EPM2A, anticorps Epm2a

UniProt: O95278

Pathways: Cellular Glucan Metabolic Process